This disconnect between clinical efficacy and real-world utilization remains one of the most persistent challenges in lipid management.
Joshua Wyatt
Advertisement
Joshua Wyatt is a senior business analyst at Lifescience Dynamics.
Articles by Joshua Wyatt
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
2
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
3
What Unexpected Costs do GLP-1 Patients Face?
4
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
5